Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients

Title
Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients
Authors
Keywords
Recurrent ovarian cancer, BRCA mutation, Relapse treatment, Chemotherapy, PARP inhibitors
Journal
GYNECOLOGIC ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2018-12-12
DOI
10.1016/j.ygyno.2018.11.036

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now